We are live on ! Find out more
Westfield Capital Management

Westfield Capital Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 49.45%
This Fund
S&P 500
This Quarter Est. Return
+13.66%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14B
AUM Growth
+$1.55B
Cap. Flow
+$55.8M
Cap. Flow %
0.4%
Top 10 Hldgs %
20.04%
Holding
266
New
32
Increased
101
Reduced
90
Closed
35

Top Buys

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$114M
2
NVS icon
Novartis
NVS
+$98.3M
3
CRI icon
Carter's
CRI
+$80.1M
4
BRX icon
Brixmor Property Group
BRX
+$77.5M
5
C icon
Citigroup
C
+$75.1M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$340M
2
ADBE icon
Adobe
ADBE
+$106M
3
MAR icon
Marriott International
MAR
+$99.8M
4
CSCO icon
Cisco
CSCO
+$81.3M
5
PGR icon
Progressive
PGR
+$62.7M

Sector Composition

Rank Sector Weight
1 Technology 27.58%
2 Healthcare 17.58%
3 Industrials 13.74%
4 Financials 11.64%
5 Consumer Discretionary 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWRE icon
126
Guidewire Software
GWRE
$13.3B
$35.3M 0.25%
321,479
-85,319
-21% -$9.54M
PFGC icon
127
Performance Food Group
PFGC
$18B
$34.8M 0.25%
676,716
+21,179
+3% +$968K
MTOR
128
DELISTED
MERITOR, Inc.
MTOR
$34.8M 0.25%
1,329,241
+375,077
+39% +$8.46M
CRL icon
129
Charles River Laboratories
CRL
$12.8B
$34.6M 0.25%
226,656
+6,998
+3% +$969K
BERY
130
DELISTED
Berry Global Group, Inc.
BERY
$33.9M 0.24%
777,078
+242,776
+45% +$9.62M
PCRX icon
131
Pacira BioSciences
PCRX
$1.02B
$33.6M 0.24%
741,389
+226,460
+44% +$9.62M
NXST icon
132
Nexstar Media Group
NXST
$5.74B
$32.7M 0.23%
278,963
+259,743
+1,351% +$27.2M
IRWD icon
133
Ironwood Pharmaceuticals
IRWD
$701M
$32.4M 0.23%
2,437,096
-85,393
-3% -$942K
GRA
134
DELISTED
W.R. Grace & Co.
GRA
$32M 0.23%
458,111
+14,061
+3% +$943K
DHI icon
135
D.R. Horton
DHI
$40.8B
$30.3M 0.22%
574,452
-165,377
-22% -$8.83M
CSGP icon
136
CoStar Group
CSGP
$12B
$30M 0.21%
500,960
-76,560
-13% -$4.47M
ALNY icon
137
Alnylam Pharmaceuticals
ALNY
$28.9B
$28.7M 0.2%
249,009
-31,288
-11% -$3.12M
XENT
138
DELISTED
Intersect ENT, Inc
XENT
$28.1M 0.2%
1,127,665
-69,261
-6% -$1.4M
RETA
139
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$27.9M 0.2%
+136,365
New +$24.9M
ZNGA
140
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$27.1M 0.19%
4,429,428
+1,489,347
+51% +$9.21M
EWBC icon
141
East-West Bancorp
EWBC
$18.1B
$26.4M 0.19%
542,970
+503,940
+1,291% +$22.7M
NUAN
142
DELISTED
Nuance Communications, Inc.
NUAN
$25.7M 0.18%
1,439,418
-239,077
-14% -$3.97M
MSA icon
143
Mine Safety
MSA
$7.48B
$24.7M 0.18%
195,392
-2,131
-1% -$256K
KN icon
144
Knowles
KN
$3.36B
$24.3M 0.17%
1,150,977
-522,075
-31% -$11.2M
APO icon
145
Apollo Global Management
APO
$73.7B
$24.3M 0.17%
509,116
+18,529
+4% +$791K
FMC icon
146
FMC
FMC
$1.32B
$24.1M 0.17%
241,106
-48,448
-17% -$4.51M
TDOC icon
147
Teladoc Health
TDOC
$1.21B
$24M 0.17%
286,581
+16,218
+6% +$1.23M
KEY icon
148
KeyCorp
KEY
$24.3B
$23.8M 0.17%
+1,177,709
New +$22.2M
CONE
149
DELISTED
CyrusOne Inc Common Stock
CONE
$23.7M 0.17%
362,605
+132,012
+57% +$9.06M
WAL icon
150
Western Alliance Bancorporation
WAL
$8.87B
$23.6M 0.17%
+413,623
New +$21.1M
4 5
6
7 8

Similar funds

Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Westfield Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Westfield Capital Management held 266 positions worth $14B, up 12% from $12.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Westfield Capital Management's Q4 2019 filing shows 32 new, 101 increased, 90 reduced and 35 closed positions. Its largest new stake was Novartis: 1,095,518 shares worth $104M. The largest sale was Medicines Co, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Westfield Capital Management's largest Q4 2019 buy was Novartis: 1,095,518 shares worth $104M.
  • Westfield Capital Management added most to TransDigm Group in Q4 2019, an estimated $114M increase.
  • Westfield Capital Management's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $340M.
  • Westfield Capital Management fully exited Adobe in Q4 2019, selling an estimated $106M.
  • Westfield Capital Management's ten largest holdings make up 20% of its $14B portfolio in Q4 2019.
  • Westfield Capital Management opened 32 new positions and closed 35 in Q4 2019.
  • Westfield Capital Management's portfolio value rose 12% quarter-over-quarter to $14B.

Based on Westfield Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.